BRAF V600E inhibitors like vemurafenib and dabrafenib are highly effective but suffer from paradoxical pathway activation. Discover how paradox breaker RAF inhibitors overcome this limitation and what they reveal about kinase inhibitor design principles.
Focal adhesion kinase (FAK) drives cancer invasion and metastasis. Explore how first-generation FAK inhibitors work, their clinical progress, and how emerging PROTAC degraders overcome their limitations. Learn about combination strategies with immunotherapy.
Tumor-associated macrophages suppress anti-cancer immunity. CSF1R inhibitors like pexidartinib reprogram these immunosuppressive cells and enhance T cell infiltration. Explore the biology, research compounds, and combination strategies.
EGFR exon 20 insertion mutations were once considered untargetable. Today, breakthrough therapies like amivantamab and sunvozertinib are changing the landscape. Explore the science behind these advances and what they mean for cancer research.
Fire blight threatens Canadian apple and pear orchards. Learn to detect Erwinia amylovora and implement integrated management strategies.
Compare ImmunoStrips, PCR, and ELISA for cannabis pathogen testing. Learn speed, cost, sensitivity, and which test is best for your facility.
Tissue culture offers cannabis producers a way to eliminate HLVd and recover clean plants from infected genetics. Learn the process and success rates.
HLVd affects 25% of Canadian cannabis facilities. Learn why licensed producers need a viroid testing protocol and how to implement one.
Cannabis Cryptic Virus and Lettuce Chlorosis Virus are emerging threats to Canadian cannabis producers. Learn how to detect these viruses before they damage your facility.
Navigate PI3K inhibitor development from pan-PI3K agents to isoform-selective compounds like alpelisib. Learn how isoform-specific biology drives targeted therapeutic approaches.
